Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

DeNovo Sciences appoints a molecular diagnostics veteran as new CSO

June 30, 2015 By MDO Editor

Yixin Wang

Dr. Wang is a veteran in molecular diagnostics where he has played significant R&D roles at large, multi-national companies.

DeNovo Sciences, a producer of  liquid biopsy products, announced the appointment of Dr. Yixin Wang as Chief Scientific Officer (CSO). Dr. Wang is a veteran in molecular diagnostics where he has played significant R&D roles at large, multi-national companies including Parke-Davis/Pfizer, Veridex/Johnson & Johnson and Ventana/Roche. He will lead strategic initiatives for clinical development of DeNovo’s technology in the U.S. and overseas. Yixin brings extensive and critical expertise from his experience on development of several cancer diagnostic technologies, especially the first and only FDA approved circulating tumor cell (CTC) technology, CellSearch from Veridex.

“I am excited to have Dr. Wang join our DeNovo team. This marks a great validation for our technology. With Yixin’s specific experience on development and commercialization of CellSearch and CTC technologies, DeNovo can now put a confident foot forward as it embarks on its own FDA trial,” said Dr. Kalyan Handique, CEO of DeNovo Sciences.

Dr. Wang has held several R&D leadership positions prior to joining DeNovo Sciences, including vice president of molecular probes at Ventana Medical Systems/Roche and executive director of R&D at Veridex. Yixin also has extensive experience working with pharmaceutical groups, identified molecular markers and developed and validated companion molecular assays. Yixin earned his Ph.D. in Molecular Biology from Cornell University and his B.S. in Biochemistry from Beijing University.

DeNovo-logo

DeNovo Sciences is a producer of liquid biopsy products.

“During my tenure at Ventana/Roche, I collaborated with the DeNovo team on validation of its CTC technology,” said Wang. “I strongly believe that the platform has a clear competitive advantage and a great potential to be applied in clinical diagnostics both in US and worldwide. It would enable molecular diagnostic tests on CTCs for many cancer types and pathways in order to deliver clinically relevant information to our customers. I look forward to working with the DeNovo team to take the technology to its fruition.”

DeNovo Sciences
www.denovosciences.com

Related Articles Read More >

A portrait of Zimmer Biomet CEO Bryan Hanson
Zimmer Biomet narrowly avoids shareholder rebuke on executive pay
Mitsubishi Gas Chemical Company BD Oxycapt syringe
BD, Mitsubishi Gas Chemical partner on better materials for plastic syringes
AdvaMed
AdvaMed joins Biden’s Joint Supply Chain Resilience Working Group
A photo of former FDA official Bakul Patel
Google Health hires FDA’s chief digital health officer

DeviceTalks Weekly.

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech